OTC naloxone is a baby step toward making the life-saving medication accessible
Critiquing profiteering by naloxone manufacturers and proposing solutions to fix this issue.
Published:
Last updated:
Jonathan JK Stoltman (PhD)
Jonathan JK Stoltman, PhD is Director of the Opioid Policy Institute. They have been an addiction scientist since 2013. Their work has appeared in leading academic journals and in the media.
All articles
Tags:
In the News
More in In the News
See all
![The Current [Lafayette, Louisiana] (4 Dec 2025)](https://storage.ghost.io/c/96/d5/96d508b5-cdb3-41b4-8b42-c402c3098b68/content/images/size/w960/format/webp/2025/12/zen_nPMHyjX6fZ.png)
